SI1117420T1 - Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues - Google Patents

Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues

Info

Publication number
SI1117420T1
SI1117420T1 SI9930098T SI9930098T SI1117420T1 SI 1117420 T1 SI1117420 T1 SI 1117420T1 SI 9930098 T SI9930098 T SI 9930098T SI 9930098 T SI9930098 T SI 9930098T SI 1117420 T1 SI1117420 T1 SI 1117420T1
Authority
SI
Slovenia
Prior art keywords
cyclodextrin
analogues
alpha
pharmaceutical compositions
oral administration
Prior art date
Application number
SI9930098T
Other languages
English (en)
Slovenian (sl)
Inventor
Remi Delansorne
Paule Bonnet
Jacques Paris
Original Assignee
Laboratoire Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex filed Critical Laboratoire Theramex
Publication of SI1117420T1 publication Critical patent/SI1117420T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
SI9930098T 1998-09-30 1999-09-23 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues SI1117420T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98402403A EP0998940A1 (en) 1998-09-30 1998-09-30 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
EP99948935A EP1117420B1 (en) 1998-09-30 1999-09-23 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues
PCT/EP1999/007389 WO2000018423A1 (en) 1998-09-30 1999-09-23 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues

Publications (1)

Publication Number Publication Date
SI1117420T1 true SI1117420T1 (en) 2002-12-31

Family

ID=8235503

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930098T SI1117420T1 (en) 1998-09-30 1999-09-23 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues

Country Status (28)

Country Link
EP (2) EP0998940A1 (xx)
JP (1) JP4485060B2 (xx)
KR (1) KR100652457B1 (xx)
CN (1) CN1200727C (xx)
AR (1) AR023056A1 (xx)
AT (1) ATE218358T1 (xx)
AU (1) AU756233B2 (xx)
BR (1) BR9914125A (xx)
CA (1) CA2344470C (xx)
CZ (1) CZ302343B6 (xx)
DE (1) DE69901721T2 (xx)
DK (1) DK1117420T3 (xx)
EE (1) EE04872B1 (xx)
ES (1) ES2178478T3 (xx)
HK (1) HK1042047B (xx)
HU (1) HUP0103649A3 (xx)
ID (1) ID28650A (xx)
IL (2) IL142112A0 (xx)
MX (1) MXPA01003340A (xx)
NO (1) NO330234B1 (xx)
NZ (1) NZ510446A (xx)
PL (1) PL200693B1 (xx)
PT (1) PT1117420E (xx)
RU (1) RU2214270C2 (xx)
SI (1) SI1117420T1 (xx)
TR (1) TR200100887T2 (xx)
WO (1) WO2000018423A1 (xx)
ZA (1) ZA200102452B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
SE0104462D0 (sv) 2001-12-29 2001-12-29 Carlbiotech Ltd As Peptide purifcation (Peptidrening)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US4659969A (en) * 1984-08-09 1987-04-21 Synektron Corporation Variable reluctance actuator having position sensing and control
PT88490B (pt) * 1987-09-14 1992-11-30 Novo Nordisk As Processo para a preparacao de composicoes farmaceuticas para libertacao nao-enterica trans-mucosa contendo monossacaridos ou oligossacaridos
SI9300470A (en) * 1993-09-10 1995-04-30 Lek Tovarna Farmacevtskih Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
EP0839525B1 (en) * 1996-10-31 2004-08-04 Takeda Chemical Industries, Ltd. Sustained-release preparation
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
RU2214270C2 (ru) 2003-10-20
IL142112A (en) 2006-10-31
ATE218358T1 (de) 2002-06-15
NO20011576L (no) 2001-03-28
AU756233B2 (en) 2003-01-09
ES2178478T3 (es) 2002-12-16
CA2344470C (en) 2009-01-06
WO2000018423A1 (en) 2000-04-06
NO330234B1 (no) 2011-03-07
PL200693B1 (pl) 2009-01-30
AR023056A1 (es) 2002-09-04
NZ510446A (en) 2003-01-31
EP1117420A1 (en) 2001-07-25
ID28650A (id) 2001-06-21
ZA200102452B (en) 2002-03-26
PT1117420E (pt) 2002-10-31
PL346939A1 (en) 2002-03-11
HUP0103649A3 (en) 2002-05-28
CN1324241A (zh) 2001-11-28
DE69901721D1 (de) 2002-07-11
CA2344470A1 (en) 2000-04-06
HK1042047B (zh) 2005-12-16
EE04872B1 (et) 2007-08-15
CZ302343B6 (cs) 2011-03-23
DK1117420T3 (da) 2002-09-16
CN1200727C (zh) 2005-05-11
KR20010075255A (ko) 2001-08-09
CZ20011173A3 (cs) 2001-09-12
DE69901721T2 (de) 2003-01-09
JP2002525336A (ja) 2002-08-13
JP4485060B2 (ja) 2010-06-16
KR100652457B1 (ko) 2006-11-30
EP0998940A1 (en) 2000-05-10
EE200100196A (et) 2002-06-17
IL142112A0 (en) 2002-03-10
BR9914125A (pt) 2001-06-19
NO20011576D0 (no) 2001-03-28
AU6199999A (en) 2000-04-17
HUP0103649A2 (hu) 2002-02-28
MXPA01003340A (es) 2004-04-21
EP1117420B1 (en) 2002-06-05
TR200100887T2 (tr) 2001-10-22

Similar Documents

Publication Publication Date Title
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
HK1034183A1 (en) Galenic formulations of meloxicam for oral administration.
HRP980163B1 (en) Pharmaceutical composition for the oral administration of an n-piperidinopyrazole -3-carboxamide derivative, its salts and their solvates
HUP0400887A3 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
HUP0004050A3 (en) Itraconazole exhibiting improved solubility, a method of preparing the same and pharmaceutical composition for oral administration comprising the same
IL133397A (en) Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin
MXPA02001631A (es) Composiciones farmaceuticas para administracion oral y topica.
HUP9903935A3 (en) Pharmaceutical compositions with vitamin d analogues
CY2313B1 (en) Rapamycin formulations for oral administration.
AU2564399A (en) Isoflavanoid formulations for oral administration
EP0953359A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
AU1732401A (en) Medicinal compositions for oral use
EP1162884A4 (en) LOW-DOSE ORAL COMPOSITIONS OF BUTYRATE COMPOSITIONS
ZA985095B (en) Rapamycin formulations for oral administration.
AU6428099A (en) Dry deodorizing composition for oral administration
IL142112A0 (en) Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues
ZA991539B (en) Oral Formulation for hyrophilic drugs.
AU3860797A (en) Pharmaceutical formulations for oral administration
AU2896897A (en) Oral pharmaceutical compositions
AU5249500A (en) Medicinal composition for oral administration
EP1133996A4 (en) DRUG COMPOSITIONS WITH PERIODIC ADMINISTRATION
HUP0101012A3 (en) Pharmaceutical composition for oral administration
GB9418029D0 (en) Pharmaceutical compositions for oral administration
AUPP915099A0 (en) Improved composition for oral administration
GB9711046D0 (en) Oral pharmaceutical compositions